Clinical Trial Update: Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 safety study of CE 224,545 in combination with methotrexate in rheumatoid arthritis has completed, focusing on safety and tolerability of the regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CE 224,545 (CE 224,545)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED